Pang Y, Holtzman N
Best Pract Res Clin Haematol. 2023; 36(2):101475.
PMID: 37353287
PMC: 10291443.
DOI: 10.1016/j.beha.2023.101475.
Kimura S, Akahoshi Y, Shiratori S, Okinaka K, Harada K, Uchida N
Open Forum Infect Dis. 2023; 10(4):ofad163.
PMID: 37089776
PMC: 10120431.
DOI: 10.1093/ofid/ofad163.
Kimura S, Shimizu H, Miyazaki T, Sakurai M, Tanoue S, Kayamori K
Bone Marrow Transplant. 2022; 58(4):452-455.
PMID: 36572728
DOI: 10.1038/s41409-022-01901-5.
Kimura S, Tamaki M, Okinaka K, Seo S, Uchida N, Igarashi A
Ann Hematol. 2021; 100(12):3029-3038.
PMID: 34490500
DOI: 10.1007/s00277-021-04660-3.
Santos E Sousa P, Bennett C, Chakraverty R
Front Immunol. 2018; 9:963.
PMID: 29770141
PMC: 5940745.
DOI: 10.3389/fimmu.2018.00963.
A Canine Model of Chronic Graft-versus-Host Disease.
Graves S, Rezvani A, Sale G, Stone D, Parker M, Rosinski S
Biol Blood Marrow Transplant. 2016; 23(3):420-427.
PMID: 28013013
PMC: 5304921.
DOI: 10.1016/j.bbmt.2016.12.629.
Classification systems for chronic graft-versus-host disease.
Lee S
Blood. 2016; 129(1):30-37.
PMID: 27821503
PMC: 5216262.
DOI: 10.1182/blood-2016-07-686642.
Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.
Ono S, Okano T, Hoshino A, Yanagimachi M, Hamamoto K, Nakazawa Y
J Clin Immunol. 2016; 37(1):85-91.
PMID: 27815752
PMC: 7101905.
DOI: 10.1007/s10875-016-0348-4.
Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center....
Hamidieh A, Behfar M, Pourpak Z, Faghihi-Kashani S, Fazlollahi M, Hosseini A
Bone Marrow Transplant. 2015; 51(2):219-26.
PMID: 26595073
DOI: 10.1038/bmt.2015.277.
Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?.
Ringden O, Labopin M, Ciceri F, Velardi A, Bacigalupo A, Arcese W
Leukemia. 2015; 30(2):447-55.
PMID: 26293645
DOI: 10.1038/leu.2015.232.
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.
Khaled S, Palmer J, Stiller T, Senitzer D, Maegawa R, Rodriguez R
Bone Marrow Transplant. 2012; 48(2):278-83.
PMID: 23000644
PMC: 3566319.
DOI: 10.1038/bmt.2012.175.
Thoracic air-leak syndromes in hematopoietic stem cell transplant recipients with graft-versus-host disease: a possible sign for poor response to treatment and poor prognosis.
Moon M, Sa Y, Cho K, Jo K, Lee S, Sim S
J Korean Med Sci. 2010; 25(5):658-62.
PMID: 20436698
PMC: 2858821.
DOI: 10.3346/jkms.2010.25.5.658.
[A rare case of a sclerodermoid chronic graft versus host disease. Successful treatment with extracorporeal photopheresis (ECP)].
Jung A, Bertsch H, Schoen M, Lippert U
Hautarzt. 2010; 61(6):514-7.
PMID: 20309512
DOI: 10.1007/s00105-010-1924-9.
MR findings in patients with disabling musculocutaneous chronic graft-versus-host disease.
Horger M, Boss A, Bethge W, Faul C, Fierlbeck G, Bornemann A
Skeletal Radiol. 2008; 37(10):885-94.
PMID: 18622607
DOI: 10.1007/s00256-008-0535-3.
Do maternal cells trigger or perpetuate autoimmune diseases in children?.
Stevens A
Pediatr Rheumatol Online J. 2007; 5:9.
PMID: 17550578
PMC: 1892552.
DOI: 10.1186/1546-0096-5-9.
Lymphocytes, cytokines and adhesion molecules in chronic graft versus host disease.
Aractingi S, Gluckman E, Le Goue C, Dubertret L, Carosella E
Clin Mol Pathol. 1996; 49(4):M225-31.
PMID: 16696080
PMC: 408064.
DOI: 10.1136/mp.49.4.m225.
12E2: a cloned murine dermal cell with features of dermal dendrocytes and capacity to produce pathologic changes resembling early Kaposi's sarcoma.
Deguchi M, Whitaker-Menezes D, Jones S, Aiba S, Nakagawa S, Tagami H
Am J Pathol. 2003; 163(5):1817-25.
PMID: 14578182
PMC: 1892424.
DOI: 10.1016/S0002-9440(10)63541-9.
Sequential morphology of graft-versus-host disease in the rat radiation chimera.
Beschorner W, Tutschka P, SANTOS G
Clin Immunol Immunopathol. 1982; 22(2):203-24.
PMID: 7049460
PMC: 7133186.
DOI: 10.1016/0090-1229(82)90038-1.
Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility.
Curtis J, Messner H
Can Med Assoc J. 1982; 126(6):649-55.
PMID: 7039802
PMC: 1863215.
Bone marrow transplantation in Canada.
Buskard N
Can Med Assoc J. 1980; 123(1):19-22.
PMID: 6998551
PMC: 1704559.